Kenneth C. Cundy's most recent trade in Anebulo Pharmaceuticals Inc was a trade of 115,037 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anebulo Pharmaceuticals Inc | Kenneth C. Cundy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 115,037 | 115,037 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Kenneth C. Cundy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 72,613 | 72,613 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Kenneth C. Cundy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 72,613 | 72,613 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Kenneth C. Cundy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 35,017 | 35,017 | - | - | Stock Option (right to buy) | |
| Anebulo Pharmaceuticals Inc | Kenneth C. Cundy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 350,169 | 350,169 | - | - | Option to purchase Common Stock | |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 11 Aug 2021 | 10,000 | 10,000 (0%) | 0% | 2.0 | 20,100 | Common Stock |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 10,000 | 750,000 | - | - | Stock Option (right to buy) | |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 11 Aug 2021 | 10,000 | 20,000 (0%) | 0% | 0.7 | 7,300 | Common Stock |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 200,000 | 200,000 | - | - | Stock Option (Right to buy) | |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.90 per share. | 16 Feb 2021 | 10,000 | 10,000 (0%) | 0% | 1.9 | 19,000 | Common Stock |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 10,000 | 760,000 | - | - | Stock Option (right to buy) | |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 16 Feb 2021 | 10,000 | 20,000 (0%) | 0% | 0.7 | 7,300 | Common Stock |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 1.90 per share. | 06 Aug 2020 | 10,000 | 10,000 (0%) | 0% | 1.9 | 19,000 | Common Stock |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2020 | 10,000 | 770,000 | - | - | Stock Option (right to buy) | |
| CohBar Inc | Kenneth C. Cundy | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.73 per share. | 06 Aug 2020 | 10,000 | 20,000 (0%) | 0% | 0.7 | 7,300 | Common Stock |